• Cloudflare Ray ID: 600ab0e03801d5f0 Hematological Oncology Impact Factor, IF, number of article, detailed information and journal factor. Current issue Browse list of issues Explore. Annals of Hematology. The criteria for acceptance are originality and high scientific quality. If you are at an office or shared network, you can ask the network administrator to run a scan across the network looking for misconfigured or infected devices. Advertisement. Subject Area and Category : Medicine Hematology Medicine (miscellaneous) Publisher: Springer Verlag: Publication type: Journals: ISSN: 14320584, 09395555: Coverage: 1991-2020: Scope: A forum for clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of hematological oncology Also covers … Citation search. Please enable Cookies and reload the page. MEDLINE® Indexed. Completing the CAPTCHA proves you are a human and gives you temporary access to the web property. It … Annals of Integrative Oncology (ISSN: 2766-144X) cover all the aspects which includes Healthcare Research, Leukemia, Immunology, medicine, genetics and other relevant topics associated within the scope of … Journal of Hematology will show case all the latest researches related to basic and clinical hematology. Citation search . Find us. Comparison of impact index for the last two years (2018 and 2017) IF of Annals of Oncology is decreased by a factor of 1.36 compared to 2017. Annals of Hematology. H Index. Compared with historical Journal Impact data, the Metric 2019 of Annals of Hematology dropped by 1.73% . In the Hematology section of Annals of Medicine we consider for publication the latest advances in: Benign Hematology: Malignant Hematology: Blood and Marrow: Transplantation: Cellular Therapy . Annals of Medicine. The Journal Impact Quartile of Annals of Oncology is Q1. 2019 Impact Factor. Change in percentage is -11.4%. Annals of Hematology. You’re seeing our new journal sites and we’d like your opinion, please send feedback. If you are on a personal connection, like at home, you can run an anti-virus scan on your device to make sure it is not infected with malware. Annals of Medicine. Compared with historical Journal Impact data, the Metric 2019 of Annals of Oncology dropped by 11.40%. Journal communicates the results of current clinical and experimental research in oncology, paying special focus on experimental therapeutics, immunotherapy and chemotherapy. Annals of Hematology & Oncology is a peer-reviewed, open access journal published by Austin Publishers. They should contain an illustrative title, but no abstract or subheadings. " Journal of Hematology & Oncology provides a forum for top-quality research and is a leading title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. Coverage includes general aspects of oncology, molecular biology and immunology as … 32 articles in this issue. It provides easy access to high quality Manuscripts covering various aspects in the field of medicine that includes early to late symptoms, diagnosis, staging, treatment, prognosis, and follow-up of two interrelated medical specialties namely hematology and oncology. Volumes and issues. The journal focuses on experimental oncology, clinical oncology and cancer epidemiology and its prevention. The ISSN of the journal is 15424863 and 00079235. Guide for Authors updated 29 July 2020. Austin Publishing Group is a successful host of more than hundred peer reviewed, open access journals in various fields of science and technology with intent to bridge the gap between academia and research access. 1.650 Hematology. The Journal Impact 2019-2020 of Annals of Hematology is 2.840, which is just updated in 2020. International Scientific Journal & Country Ranking. 1.650 Search in: Advanced search. Annals of Oncology IF is decreased by a factor of 1.36 and approximate percentage change is -11.4% when compared to preceding year 2017, which shows a falling trend. Volumes and issues listings for Annals of Hematology. Instructions for Authors Submit Now. This will help the hematologists for understanding, diagnosis, treatment and prevention of any type of disorders related to blood, bone marrow transplantation, circulatory system and hemostasis systems. Annals of Hematology & Oncology is a peer-reviewed, open access journal published by Austin Publishers. It provides easy access to high quality Manuscripts covering various aspects in the field of medicine that includes early to late symptoms, diagnosis, staging, treatment, prognosis, and follow-up of two interrelated medical specialties namely hematology and oncology. Seminars in Hematology is a review journal dedicated to subjects of current importance in clinical hematology, including related areas of oncology, hematopathology, and blood banking.. Every issue is edited by a guest editor or editors, an internationally acknowledged expert(s) in the field, and contains authoritative invited reviews on different aspects of the subject area. Journal home; Volumes and issues; Search within journal . It provides easy access to high quality Manuscripts covering various aspects in the field of medicine that includes early to late symptoms, diagnosis, staging, treatment, prognosis, and follow-up of two interrelated medical specialties namely hematology and oncology. Two-Year Impact Factor 3.243 Five-Year Impact Factor 3.840. The journal also publishes reviews and research highlights from leading experts in the field. Search Log in; Search SpringerLink. Only Open Access Journals Only SciELO Journals Only WoS Journals Volume 99 January - December 2020. The Journal Impact Quartile of Annals of Hematology is Q1 . CiteScore 5.70. Annals of Medical and Clinical Oncology is a peer-reviewed journal dedicated towards cancer research. Search. Annals of Hematology & Oncology accepts original research articles, review articles, case reports, mini reviews, rapid communication, opinions and editorials on all the related aspects of hematology and oncology. ISSN: 0278-0232. Oncology & Hematology 2017 - Impact Factor Ranking - Impact Factor Lists 2017 Journals Impact Factor Ranking Lists 2017 … Annals of Integrative Oncology (ISSN: 2766-144X) is an open access, peer reviewed, International, multidisciplinary journal dedicated to promote research outcomes in cancer therapy. Austin Clinical Medicine Specialty Portals, COVID-19 in a Patient with Multisystemic Langerhans Cell Histiocytosis, Myeloid Sarcoma of Nasal Cavity: An Unusual Presentation for Chronic Myelogenous Leukemia, Anti-BCMA CAR-T Administration in a Relapsed and Refractory Multiple Myeloma Patient after COVID-19 Infection, Many Faces of COVID-19 Pneumonia in Male Cancer Patients, Severe Pancytopenia after Obinutuzumab-Chlorambucil Therapy for CLL with Fatal Outcome. About Journal. Letters to the Editor: Comments on published papers or reports of illustrative cases are welcome, but should not exceed 500 words, 10 references, and 1 figure/table. This journal also focuses upon the study of blood, the blood-forming organs, and blood diseases, cancer etiology, diagnosis, staging, treatment, drugs, epidemiology, and awareness. The subject area includes Hematology-Oncology. Q1 Rank. Journal Annals Of Hematology Impact Factor - ISSN : 0939-5555. Annals of Hematology covers the whole spectrum of clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of medical oncology, including diagnosis and treatment of leukemias, lymphatic neoplasias and solid tumors, and transplantation of hematopoietic stem cells. Volume 99, issue 6, June 2020. The impact factor (IF) 2018 of Annals of Oncology is 10.57, which is computed in 2019 as per it's definition. Scimago Journal Rank indicator (SJR) is a measure of journal impact, influence, or prestige. Citation Impact 11.059 - 2-year Impact Factor 8.474 - 5-year Impact Factor 1.923 - Source Normalized Impact per Paper (SNIP) 3.231 - SCImago Journal Rank (SJR) Usage 982,034 Downloads 845 … • The Journal Impact 2019-2020 of Annals of Oncology is 10.570, which is just updated in 2020. Potential Financial Conflicts of Interest:Consultancies: GlaxoSmithKline.Honoraria: Baxter, GlaxoSmithKline, Sanofi-Aventis. New content alerts RSS. Search. Impact Factor: 18.274 ℹ Impact Factor: 2019: 18.274 The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. Performance & security by Cloudflare, Please complete the security check to access. Medtext Publications LLC is an open access platform and publishes multidisciplinary journals in the fields of clinical, medical, pharmaceutical and life sciences. About this journal. Country: Germany - 77. Journal home; Volumes and issues; Volume 99, issue 6; Search within journal . Here You will find a list of all available journals concerning Oncology ranked by their current Impact Factor.